Company: STAA
Filing Date: 2025-12-10
Form Type: DFAN14A
Source: 0001213900-25-120140
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DFAN14A
Chunk 3
---
Exhibit 2

<div align='center'>Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer

Believes STAAR’s Sale Process Was Structured to Seal the Alcon Deal, Not to Maximize Value for Shareholders

The Company Is Not Ripe for Sale at This Time

Continues to Urge STAAR Shareholders to Vote “ AGAINST” the Proposed Transaction</div>

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited
(together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder
of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today released the following letter to STAAR
shareholders regarding the closing of STAAR’s go-shop period and the revised offer of Alcon Inc. (SIX/NYSE: ALC) to acquire STAAR
for $30.75 per share.

The text of the letter is as follows:

December 10, 2025

Dear Fellow STAAR Shareholders:

We are writing to share with you our continued
opposition to the proposed transaction. After reviewing the announcements by STAAR and Alcon regarding the course and closing of the 30-day
go-shop period, and Alcon’s revised offer of $30.75 per share, we remain opposed to the merger even at the increased price and will continue to vote our shares AGAINST it.

We strongly believe that it is still not the right time to sell the Company – regardless of the outcome of the go-shop period.We held this view before the go-shop
was initiated, as we communicated to shareholders and to the Board on several occasions. We held this view during the go-shop period,
although we chose not to publicly express that view during the period so as not to prejudice the process. And we continue to hold this
view now that the go-shop has concluded and predictably produced no additional proposal.

We also believe that STAAR has mismanaged its
attempt to sell the Company from the start; that the go-shop process was structured and conducted to seal the Alcon deal rather than to
genuinely seek additional offers; and that the Company has not been fully transparent with shareholders, including in its most recent
press release. With these views in mind, we are even more resolved to vote against the proposed merger, even at the revised price.

There may come a time when a